Quality Assessment of Original and Generic Formulations of Injectable Cefazolin Sodium Products

DOI NDL Digital Collections 4 Citations 6 References
  • Kimura Yasuhiro
    Department of Pharmaceutical Services,Hiroshima University Hospital
  • Ohhama Osamu
    Faculty of Pharmacy,Fukuyama University
  • Doi Honami
    Department of Pharmaceutical Services,Hiroshima University Hospital
  • Shibata Yuuka
    Department of Pharmaceutical Services,Hiroshima University Hospital
  • Kihira Kenji
    Department of Pharmaceutical Services,Hiroshima University Hospital

Bibliographic Information

Other Title
  • 注射用セファゾリンナトリウム製剤の先発医薬品と後発医薬品における品質比較

Search this article

Description

Very little information is available on the quality of generic products and it has recently been reported that anaphylaxy shock occurred when a generic formulation of an injectable cefazolin sodium product was used in a patient before surgery.This suggests that the generic product contained impurities that caused such an adverse reaction.It is therefore important to determine the constituents of generic products and compare them with those of the original products.<br>We analyzed the original cefazolin sodium product and 4 generics of it by means of high performance liquid chromatography in order to determine differences in quality between them.Three impurities were found in the original product and 4 in the generic products,respectively.However,the impurity content of all of the generic products was significantly higher than that of the original product and on analyzing synthetic samples of impurities which could possibly be contained in the cefazolin sodium products,the chromatographic peaks of three of them overlapped with the peaks observed in the chromatograms of the original and generic products.<br>These results suggest that there can be great differences in quality between the original and generic products,and that the impurities might be cefazolin-related substances.We must therefore select generics based on an appraisal of the quality information available for them in order to minimize unexpected adverse reactions and achieve more cost effective and safe therapy.

Journal

Citations (4)*help

See more

References(6)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top